Transgene Biotek Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Sep ' 25	Sep ' 24	Sep ' 23	Sep ' 22	Mar ' 22

Sales

0.10

0.11

0.14

0.06

0.09

Operating profit

-0.21

-0.49

-0.24

-0.68

-0.22

Interest

0.51

0.03

0.06

0.09

0.11

Gross profit

-0.72

0.17

-0.22

-0.68

-0.20

EPS (Rs)

-0.11

0.02

-0.03

-0.42

-0.68

Other income

-

0.70

0.09

0.09

0.12

Stock adjustment

-

-

-

-

-0.07

Raw material

-

-

-

-

0.02

Power and fuel

-

-

-

-

-

Employee expenses

0.08

0.16

0.16

0.15

0.16

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

0.23

0.43

0.23

0.58

0.20

Provisions made

-

-

-

-

-

Depreciation

0.10

0.05

0.05

2.48

4.98

Taxation

-

-

-

-

-

Net profit / loss

-0.82

0.13

-0.26

-3.16

-5.19

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

75.77

75.77

75.77

75.77

75.77

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-207.92

-453.95

-166.25

-1233.73

-254.23

GPM (%)

-

21.46

-93.64

-478.07

-97.52

NPM (%)

-

15.67

-113.50

-2211.68

-2472.36